ReviewPediatrics2019
Ensuring the Life-Span Benefits of Newborn Screening.
Review in Pediatrics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- A 25-Year Retrospective on Bavaria's Newborn Screening Programme: Achievements, Challenges and Long-Term Follow-Up.International journal of neonatal screening · 2025Article
- [Development of a quality control indicator system for neonatal screening of inherited metabolic diseases in obstetric settings].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2025Article
- Parent Reports of Developmental Service Utilization After Newborn Screening.International journal of neonatal screening · 2024Article
- An insight into Indonesia's progress for newborn screening program: What is currently going on.Heliyon · 2024Article
- Defining the Minimal Long-Term Follow-Up Data Elements for Newborn Screening.International journal of neonatal screening · 2024Article
- Advancing Newborn Screening Long-Term Follow-Up: Integration ofInternational journal of neonatal screening · 2024Article
- Landscape Analysis of Neurodevelopmental Comorbidities in Newborn Screening Conditions: Challenges and Opportunities.International journal of neonatal screening · 2024Article
- Population health management genomic new-born screens and multi-omics intercepts.Frontiers in artificial intelligence · 2024Review
- Is Our Newborn Screening Working Well? A Literature Review of Quality Requirements for Newborn Blood Spot Screening (NBS) Infrastructure and Procedures.International journal of neonatal screening · 2023Review
- Evidence and recommendation for mucopolysaccharidosis type II newborn screening in the United States.Genetics in medicine : official journal of the American College of Medical Genetics · 2023Review
- The promise of public health ethics for precision medicine: the case of newborn preventive genomic sequencing.Human genetics · 2022Review
- Following Patients With Inborn Errors of Metabolism: What Do We Value and How Do We Know?Pediatrics · 2021Article
- The diagnosis of inborn errors of metabolism in previously undiagnosed adults referred for medical genetics evaluation.Molecular genetics and metabolism reports · 2020Article
- Treatment Discontinuation within 3 Years of Levothyroxine Initiation among Children Diagnosed with Congenital Hypothyroidism.The Journal of pediatrics · 2020Article
- The First Year Experience of Newborn Screening for Pompe Disease in California.International journal of neonatal screening · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.